Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

They shared the Nobel Prize in Chemistry for their CRISPR work eight years later. The Broad Institute applied for its own patent covering the use of CRISPR in "eukaryotic" plant or animal cells in ...

Her Nobel Prize win in 2020, just eight years after Crispr’s discovery, demonstrates the seismic impact this technology has ...

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and only ...

But now, in a surprise twist, the team that earned the Nobel Prize in chemistry for developing CRISPR is asking to cancel two of their own seminal patents, MIT Technology Review has learned.

CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...

The Nobel Prize in chemistry is awarded to Jennifer Doudna of UC Berkeley and Emmanuelle Charpentier for their work on the CRISPR gene-editing tool. Oct. 7, 2020 More about the Nobels ...

Only eight women have ever won the Chemistry Nobel Prize, out of 114 prizes and 189 prize winners. ... CRISPR/Cas9 allows scientists to precisely cut out genes and swap them between organisms, ...

Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by Dr. Jennifer Doudna who won the Nobel Prize for the life saving technology.

Dec. 5, 2022 — CRISPR, the Nobel Prize-winning gene editing technology, is poised to have a profound impact on the fields of microbiology and medicine yet again.

In his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for future health crises and how gene editing with CRISPR factors in.

In his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for future health crises and how gene editing with CRISPR factors in.